News

Decitabine for injection is a generic version of Japanese pharmaceutical firm Eisai’s Dacogen. The drug is used to treat patients with myelodysplastic syndromes (MDS) including previously treated and

Scheduled to be initiated within weeks, the dose ranging efficacy trial in an experimental Ebola virus disease model in non-human primates represents a major step towards understanding the

LCZ696 is a twice a day tablet being investigated for heart failure and is indicated to reduce the strain on the failing heart. The company said that LCZ696

In order to solve the problems with our healthcare systems, as well as the patients, we need to look at the healthy that benefit from over the counter

Copaxone is marketed for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS). Multiple sclerosis is a chronic disease of the central nervous system (CNS) characterized by inflammation and neurodegeneration.

The YUKAWA-2 (StudY of LDL-Cholesterol Reduction Using a Monoclonal PCSK9 Antibody in Japanese Patients With Advanced Cardiovascular Risk) trial met its co-primary endpoints: the percent reduction from baseline

BTG and SciClone previously entered into an agreement granting SciClone exclusive licensing and distribution rights to DC Bead in China. Under the agreement, SciClone will purchase product from

The clinical test are being conducted through Immunotech Laboratories, BG ("IMMB-BG") a 49% owned subsidiary of Immunotech Laboratories. Since 2013, IMMB-BG hired and funded the Clinical Research Organization

The first newly allowed patent application (serial No: 05723389.2) entitled "Systems and Methods for Clonal Expression in Plants," includes claims to a system for generating transgenic hairy root